SPDR S&P Pharmaceuticals ETF
XPH
XPH
69 hedge funds and large institutions have $93.1M invested in SPDR S&P Pharmaceuticals ETF in 2022 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 19 increasing their positions, 24 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
41% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 17
44% less call options, than puts
Call options by funds: $420K | Put options by funds: $756K
Holders
69
Holding in Top 10
–
Calls
$420K
Puts
$756K
Top Buyers
| 1 | +$2.2M | |
| 2 | +$1.47M | |
| 3 | +$746K | |
| 4 |
Jane Street
New York
|
+$553K |
| 5 |
Millennium Management
New York
|
+$327K |
Top Sellers
| 1 | -$3.14M | |
| 2 | -$2.63M | |
| 3 | -$1.93M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$1.71M |
| 5 |
FIM
FWL Investment Management
Dallas,
Texas
|
-$1.68M |